Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2001, p. 3231-3233, Vol. 45, No. 11
Departments of Medicine and Microbiology,
Duke University Medical Center, Durham, North
Carolina,1 and University Center for
Medical Mycology, Case Western Reserve University, Cleveland,
Ohio2
Received 25 January 2001/Returned for modification May
2001/Accepted 13 August 2001
It has been postulated that phospholipases of fungal origin can
affect in vitro susceptibility testing of amphotericin B lipid complex
(ABLC). We used specific phospholipase-deficient mutants of
Candida albicans and Cryptococcus neoformans in
susceptibility testing and demonstrated that extracellular fungal
phospholipase activity does not influence the in vitro susceptibilities
of these two fungi to ABLC.
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.11.3231-3233.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Fungal Phospholipase Activity and Susceptibility to
Lipid Preparations of Amphotericin B
*
Corresponding author. Mailing address: Box 3281, Duke
Medical Center, Durham, NC 27710. Phone: (919) 681-5055. Fax: (919) 684-8902. E-mail: gary.cox{at}duke.edu.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»